These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25760340)

  • 1. Therapeutic options and emerging alternatives for multidrug resistant staphylococcal infections.
    Magana M; Ioannidis A; Magiorkinis E; Ursu O; Bologa CG; Chatzipanagiotou S; Hamblin MR; Tegos GP
    Curr Pharm Des; 2015; 21(16):2058-72. PubMed ID: 25760340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing the power of light to treat staphylococcal infections focusing on MRSA.
    Agrawal T; Avci P; Gupta GK; Rineh A; Lakshmanan S; Batwala V; Tegos GP; Hamblin MR
    Curr Pharm Des; 2015; 21(16):2109-21. PubMed ID: 25760339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marine bacteria: potential sources for compounds to overcome antibiotic resistance.
    Eom SH; Kim YM; Kim SK
    Appl Microbiol Biotechnol; 2013 Jun; 97(11):4763-73. PubMed ID: 23640363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model.
    Lowrence RC; Raman T; Makala HV; Ulaganathan V; Subramaniapillai SG; Kuppuswamy AA; Mani A; Chittoor Neelakantan S; Nagarajan S
    Appl Microbiol Biotechnol; 2016 Nov; 100(21):9265-9281. PubMed ID: 27531512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of infections due to resistant Staphylococcus aureus.
    Anstead GM; Cadena J; Javeri H
    Methods Mol Biol; 2014; 1085():259-309. PubMed ID: 24085702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel antibacterial modalities against methicillin resistant
    Li J; Liu D; Tian X; Koseki S; Chen S; Ye X; Ding T
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S153-S161. PubMed ID: 30501508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: a case-based review.
    Reddy P; Chadaga S; Noskin GA
    J Hosp Med; 2009 Jul; 4(6):E8-15. PubMed ID: 19670375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic Resistance and the MRSA Problem.
    Vestergaard M; Frees D; Ingmer H
    Microbiol Spectr; 2019 Mar; 7(2):. PubMed ID: 30900543
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-infective drug development for MRSA.
    Daniel A
    Methods Mol Biol; 2014; 1085():311-31. PubMed ID: 24085703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.
    Bal AM; David MZ; Garau J; Gottlieb T; Mazzei T; Scaglione F; Tattevin P; Gould IM
    J Glob Antimicrob Resist; 2017 Sep; 10():295-303. PubMed ID: 28732783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus.
    Narayanaswamy VP; Giatpaiboon SA; Uhrig J; Orwin P; Wiesmann W; Baker SM; Townsend SM
    PLoS One; 2018; 13(1):e0191522. PubMed ID: 29342216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin.
    Gasch O; Camoez M; Domínguez MA; Padilla B; Pintado V; Almirante B; Martín C; López-Medrano F; de Gopegui ER; Blanco JR; García-Pardo G; Calbo E; Montero M; Granados A; Jover A; Dueñas C; Pujol M;
    J Antimicrob Chemother; 2014 Feb; 69(2):568-71. PubMed ID: 24107389
    [No Abstract]   [Full Text] [Related]  

  • 13. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal.
    Adhikari RP; Shrestha S; Barakoti A; Amatya R
    BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-Molecule Potentiators for Conventional Antibiotics against Staphylococcus aureus.
    Vermote A; Van Calenbergh S
    ACS Infect Dis; 2017 Nov; 3(11):780-796. PubMed ID: 28889735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
    Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
    J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug efflux pumps in Staphylococcus aureus and their clinical implications.
    Jang S
    J Microbiol; 2016 Jan; 54(1):1-8. PubMed ID: 26727895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonconventional Therapeutics against
    Grunenwald CM; Bennett MR; Skaar EP
    Microbiol Spectr; 2018 Nov; 6(6):. PubMed ID: 30547858
    [No Abstract]   [Full Text] [Related]  

  • 18. Attaching the NorA Efflux Pump Inhibitor INF55 to Methylene Blue Enhances Antimicrobial Photodynamic Inactivation of Methicillin-Resistant Staphylococcus aureus in Vitro and in Vivo.
    Rineh A; Dolla NK; Ball AR; Magana M; Bremner JB; Hamblin MR; Tegos GP; Kelso MJ
    ACS Infect Dis; 2017 Oct; 3(10):756-766. PubMed ID: 28799332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative therapies in Staphylococcus aureus diseases.
    Kurlenda J; Grinholc M
    Acta Biochim Pol; 2012; 59(2):171-84. PubMed ID: 22577619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antibiotics effective against gram-positive and -negative multi-resistant bacteria with limited resistance.
    Nicolas I; Bordeau V; Bondon A; Baudy-Floc'h M; Felden B
    PLoS Biol; 2019 Jul; 17(7):e3000337. PubMed ID: 31287812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.